Claudio Bonifati
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study.
Journal: The Journal of dermatological treatment
Published: February 06, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.
Journal: Dermatology and therapy
Published: November 25, 2025
Psoriasis in Difficult-to-Treat Areas: A Multicentre, Real-World Retrospective Study Analyzing the Impact of Non-Invasive Imaging Techniques (Dermoscopy, Reflectance Confocal Microscopy and Optical Coherence Tomography) to Monitor the Effectiveness of Risankizumab in the Treatment of Plaque Psoriasis of the Legs.
Journal: Clinics and practice
Published: November 19, 2025
Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study.
Journal: Psoriasis (Auckland, N.Z.)
Published: April 08, 2025
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study.
Journal: Dermatology and therapy
Published: February 24, 2025
A long-term real-world safety study of guselkumab in patients with psoriasis who have infectious comorbidities, malignancies or heart disease: the EARLY study.
Journal: Clinical and experimental dermatology
Published: February 19, 2025
CORONATE: A Novel Questionnaire to Assess the Long-Term Impact of Psoriasis on Patients' Lives.
Journal: Dermatology practical & conceptual
Published: January 17, 2025
Psoriasis and Emotional Dysregulation: A Multicenter Analysis of Psychodermatology Outcomes.
Journal: Dermatology practical & conceptual
Published: December 27, 2024
The role of guselkumab in psoriatic artrithis and disease progression in patients with confirmed diagnosis of enthesitis.
Journal: Italian journal of dermatology and venereology
Published: June 03, 2024
Effectiveness and safety of risankizumab in VEry severe plaque psoriasis: a real-life retrospective study (VESPA-Study).
Journal: The Journal of dermatological treatment
Published: May 22, 2024
Upadacitinib in the treatment of difficult-to-treat psoriatic arthritis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 06, 2024
Last Updated: 09/26/2026